Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell R Smith

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Cancer Research|September 19, 2007
Aberrant Huntingtin interacting protein 1 in lymphoid malignanciesSarah V Bradley, Mitchell R Smith, Teresa S Hyun, et al.
Leukemia Research|August 7, 2002
Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytesSuzanne E Franks, Mitchell R Smith, Fernando Arias-Mendoza, et al.
Journal of Sports Sciences|March 28, 2020
Understanding the presence of mental fatigue in English academy soccer playersChris J Thompson, Mark Noon, Chris Towlson, et al.
Blood|April 25, 2015
CCMCL1: a new model of aggressive mantle cell lymphomaXiaoxian Zhao, Selina Chen-Kiang, Shashirekha Shetty, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General PopulationYazan F Madanat, Lisa Rybicki, Tomas Radivoyevitch, et al.
Leukemia & Lymphoma|July 12, 2017
A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphomaBrian T Hill, Mitchell R Smith, Meredeth Shelley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2018
Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged MiceKyoko Hayakawa, Anthony M Formica, Yuka Nakao, et al.
Plos One|March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosisSurbhi Sidana, Mayur Narkhede, Paul Elson, et al.
Therapeutic Advances in Hematology|April 7, 2018
Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplantJoshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2017
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab EraMoaath Mustafa Ali, Lisa Rybicki, Laila Nomani, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Cancer Research|September 19, 2007
Aberrant Huntingtin interacting protein 1 in lymphoid malignanciesSarah V Bradley, Mitchell R Smith, Teresa S Hyun, et al.
Leukemia Research|August 7, 2002
Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytesSuzanne E Franks, Mitchell R Smith, Fernando Arias-Mendoza, et al.
Journal of Sports Sciences|March 28, 2020
Understanding the presence of mental fatigue in English academy soccer playersChris J Thompson, Mark Noon, Chris Towlson, et al.
Blood|April 25, 2015
CCMCL1: a new model of aggressive mantle cell lymphomaXiaoxian Zhao, Selina Chen-Kiang, Shashirekha Shetty, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2017
Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General PopulationYazan F Madanat, Lisa Rybicki, Tomas Radivoyevitch, et al.
Leukemia & Lymphoma|July 12, 2017
A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphomaBrian T Hill, Mitchell R Smith, Meredeth Shelley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2018
Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged MiceKyoko Hayakawa, Anthony M Formica, Yuka Nakao, et al.
Plos One|March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosisSurbhi Sidana, Mayur Narkhede, Paul Elson, et al.
Therapeutic Advances in Hematology|April 7, 2018
Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplantJoshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2017
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab EraMoaath Mustafa Ali, Lisa Rybicki, Laila Nomani, et al.
Pageof 13